| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/15/1997 | EP0693926B1 Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide |
| 01/15/1997 | EP0642332B1 Ophthalmic compositions containing a cyclosporin |
| 01/15/1997 | EP0625178B1 Improved processes for the manufacture of enriched pitches and carbon fibers |
| 01/15/1997 | EP0594770B1 Oxicam or oxicam derivatives-containing ophthalmic compositions |
| 01/15/1997 | EP0346375B1 Plant gum material and use thereof in food products |
| 01/15/1997 | CN1140415A Treatment of antibiotic associated diarrhea |
| 01/15/1997 | CN1140412A Percutaneously absorbable preparation |
| 01/15/1997 | CN1140411A Oral liquid compositions contg. paroxetine resinate |
| 01/15/1997 | CN1140406A Oil-in-water emulsions |
| 01/15/1997 | CN1140405A Lipophilic carrier preparations |
| 01/15/1997 | CN1140091A Bitterness-relieving agent |
| 01/15/1997 | CN1033790C Process for stabilizing omeprazole and benzimidazole derivs |
| 01/14/1997 | US5594136 Useful in the separation of neutral and anionic species, phosphate ester hydrolysis, magnetic resonance imaging and photodynamic therapy |
| 01/14/1997 | US5594122 Bind to conserved regions of human immunodeficiency virus genetic material to prevent expression thereof |
| 01/14/1997 | US5594110 Process of conjugation of antiviral nucleosides with lactosaminated human albumin |
| 01/14/1997 | US5594030 Controlled release pharmaceutical compositions based on one or more pharmaceutically acceptable salts of gamma hydroxy-butyric acid |
| 01/14/1997 | US5594013 Polyvinylpyrrolidone and an acrylic polymer, slow release |
| 01/14/1997 | US5593978 Growth promoting composition for fish and method of using the same |
| 01/14/1997 | US5593959 Anticoagulants |
| 01/14/1997 | US5593695 Morphine therapy |
| 01/14/1997 | US5593691 Diesters and unsaturated diesters with cosmetics, drugs and tensides |
| 01/14/1997 | US5593690 Sustained release preparations |
| 01/14/1997 | US5593685 Ranitidine compositions |
| 01/14/1997 | US5593683 Drug delivery |
| 01/14/1997 | US5593675 Method of producing an anti-D immunoglobulin concentrate and a pharmaceutical preparation |
| 01/14/1997 | US5593658 Medical compositions |
| 01/14/1997 | US5593622 Preparation of liposomes with peg-bound phospholipid on surface |
| 01/14/1997 | US5593502 Method of making crystalline sugar and products resulting therefrom |
| 01/14/1997 | CA2046930C Stabilisation of k1k2p pro |
| 01/14/1997 | CA2046929C T-pa pro stabilisation |
| 01/14/1997 | CA2046598C T-pa solubilisation |
| 01/14/1997 | CA1338839C Controlled release formulation |
| 01/13/1997 | CA2180215A1 Medicament for nasal administration |
| 01/13/1997 | CA2153733A1 Immunogenic oligosaccharide compositions |
| 01/13/1997 | CA2153730A1 Immunostimulating activity of streptococcus pneumoniae serotype 8 oligosaccharides |
| 01/09/1997 | WO1997000960A1 Novel human chemotactic cytokine |
| 01/09/1997 | WO1997000889A1 Peptides binding to low-density lipoproteins |
| 01/09/1997 | WO1997000693A1 Novel formulation for peptide release |
| 01/09/1997 | WO1997000688A1 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders |
| 01/09/1997 | WO1997000671A2 Composition for preparing finely dispersed systems and process for preparing the same |
| 01/09/1997 | WO1997000670A1 A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof |
| 01/09/1997 | WO1997000669A1 Compositions and methods for stabilizing polymers |
| 01/09/1997 | WO1997000668A1 Stable hydroalcoholic compositions |
| 01/09/1997 | WO1997000663A1 Composition including a dispersion of polymeric particles in a non-aqueous medium |
| 01/09/1997 | WO1997000638A2 Apparatus and method for making gas-filled vesicles of optimal size |
| 01/09/1997 | WO1996032137A3 Methods of inducing immune tolerance using immunotoxins |
| 01/09/1997 | DE19524515A1 Saccharid-Konjugate Saccharide conjugates |
| 01/09/1997 | CA2224702A1 Stable hydroalcoholic compositions |
| 01/09/1997 | CA2219739A1 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders |
| 01/08/1997 | EP0752457A2 Hydrophilic adhesive base material |
| 01/08/1997 | EP0752248A1 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 01/08/1997 | EP0752005A1 Compacted nucleic acids and their delivery to cells |
| 01/08/1997 | EP0752004A1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
| 01/08/1997 | EP0752003A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 01/08/1997 | EP0751789A1 Gel for treatment of skin diseases and for disinfection of the skin |
| 01/08/1997 | EP0751776A1 Novel pharmaceutical composition for skin diseases |
| 01/08/1997 | EP0751771A1 Pharmaceutical formulations containing beta-lactam antibiotics and an alkyl sulphate surfactant |
| 01/08/1997 | EP0751764A1 Retinal-containing composition |
| 01/08/1997 | EP0620728B1 Preparation of tablets of increased strength |
| 01/08/1997 | EP0591204B1 Pharmaceutical formulations |
| 01/08/1997 | EP0568577B1 Orally administerable drugs for the treatment of central dopamine deficiency conditions |
| 01/08/1997 | EP0558586B1 A gel-forming liquid carrier composition |
| 01/08/1997 | EP0551411B1 Ionically cross-linked polymeric microcapsules |
| 01/08/1997 | CN1139932A N-terminally chemically modified protein compositions and methods |
| 01/08/1997 | CN1139881A Aqueous topical compositions |
| 01/08/1997 | CN1139878A Intraorally soluble compressed molding and process for producing the same |
| 01/08/1997 | CN1139877A Rapidly dissolving oral dosage form |
| 01/08/1997 | CN1033738C Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing same |
| 01/07/1997 | US5591774 Method of treating wrinkles using malic acid |
| 01/07/1997 | US5591731 Crystalline amifostine compositions |
| 01/07/1997 | US5591730 Inhibition of urinary calculi growth |
| 01/07/1997 | US5591715 Fatty diester, diamide or diether of polyoxyethylene glycol |
| 01/07/1997 | US5591713 Water-soluble composition for sustained-release |
| 01/07/1997 | US5591710 Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute |
| 01/07/1997 | US5591631 Anthrax toxin fusion proteins, nucleic acid encoding same |
| 01/07/1997 | US5591453 Incorporation of biologically active molecules into bioactive glasses |
| 01/07/1997 | US5591452 Controlled release formulation |
| 01/07/1997 | US5591433 Oral administration of immunologically active biomolecules and other therapeutic proteins |
| 01/07/1997 | CA2111122C Aqueous emulsions & aerosol delivery system using same |
| 01/07/1997 | CA2070803C Biodegradable implant material and process for producing same |
| 01/07/1997 | CA2038097C Method and composition for coiontophoresis |
| 01/07/1997 | CA2029050C Sustained release compositions for treating periodontal disease |
| 01/07/1997 | CA2025315C Protein-containing aqueous solutions |
| 01/07/1997 | CA2008509C Stabilizing system for solid dosage forms |
| 01/07/1997 | CA1338826C Method upon a temperature increase of counteracting a viscosity decrease or providing a viscosity increase in a water-base system containing a polymer as viscosity agent |
| 01/05/1997 | CA2180084A1 Hydrophilic adhesive base material |
| 01/03/1997 | WO1997000275A2 Responsive polymer networks and methods of their use |
| 01/03/1997 | WO1997000236A1 Multifunctional cross-linking reagents for hemoglobin, and cross-linked hemoglobin conjugates |
| 01/03/1997 | CA2230727A1 Responsive polymer networks and methods of their use |
| 01/02/1997 | EP0751221A1 Recombinant mistletoe lectin (rML) |
| 01/02/1997 | EP0751170A2 Silicone derivatives, their production and use |
| 01/02/1997 | EP0751150A1 Cyclodextrin derivatives, their preparation and their use to incorporate hydrophobic molecules in organized surfactant systems |
| 01/02/1997 | EP0751129A1 Substituted dihydrodibenzo/b, f/azepines, method for their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them |
| 01/02/1997 | EP0750913A2 Disaccharide containing freeze-dried preparation for pharmaceutical use |
| 01/02/1997 | EP0750907A2 Stable macrolide and macrolide vaccine compositions |
| 01/02/1997 | EP0750849A1 Taste modifier |
| 01/02/1997 | EP0750676A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf) |
| 01/02/1997 | EP0750675A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF) |
| 01/02/1997 | EP0750674A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-$g(b)) |
| 01/02/1997 | EP0750649A1 Branched polyoxaalkyl macromolecules, process for making them and their uses |